We use cookies to give you a better Web experience. By visiting our website you agree to our use of cookies. Read about cookies
OK
  1. Home
  2. Mandates
  3. Vinge advises IRLAB Therapeutics in connection with share issues

Assignment Vinge advises IRLAB Therapeutics in connection with share issues

December 13, 2019

Vinge advises IRLAB Therapeutics in connection with a directed share issue of SEK 70 million and a rights issue of approximately SEK 145 million.

The directed share issue was subscribed for by a number of institutional and qualified investors on the basis of an accelerated book building process. The rights issue is expected to be completed during the first quarter of 2020.

IRLAB Therapeutics is a research and development company, listed on Nasdaq First North Premier Growth Market, focused on development of novel therapies for the treatment of neurodegenerative diseases, in particular Parkinson’s disease and dementia.

Vinge’s team has consisted of Dain Hård Nevonen, Nils Fredrik Dehlin, Stephanie Stiernstedt, Stojan Arnerstål, Anna Thoms and Maria Schultzberg.

Share

Employment law podcast – our first episode in English

 By popular request, here is our very first English-language episode of Vinge's employment law podcast Arbetsrättspodden.
November 28, 2019

Viveka Classon new partner in Stockholm

 Viveka Classon has been elected as a new partner at Vinge’s Stockholm office.
November 14, 2019

Maria-Pia Hope wins the Swedish Bar Association’s award for outstanding work within the legal profession

 For the eighth year in a row, the Swedish Bar Association has issued the award for outstanding achievements within the legal profession. In 2019, the award goes to Maria-Pia Hope, Managing Partner at Advokatfirman Vinge.
October 25, 2019